Description: REZUROCK is the first and only treatment for cGVHD that selectively inhibits the ROCK2 pathway.
Example domain paragraphs
For US Health Care Professionals Only
An innovative way to treat cGVHD 1-3
REZUROCK is the first and only treatment for cGVHD that selectively inhibits the rock2 pathway. REZUROCK is an immunomodulator that is designed to downregulate inflammation and fibrosis. 1-3
Links to rezurockhcp.com (6)
alprolixpro.comHemophilia B coagulation Factor IX concentrate for adults and children | ALPROLIX® Professional
rezurock.comREZUROCK® (belumosudil) | Official Patient Website